Valuation: Evaxion A/S

Market Cap 2.74Cr 2.43Cr 2.27Cr 2.07Cr 3.89Cr 263.46Cr 3.95Cr 27Cr 11Cr 134.25Cr 10Cr 10Cr 432.35Cr P/E 2026 *
-79.5x
P/E 2027 * -212x
Enterprise Value 2.74Cr 2.43Cr 2.27Cr 2.07Cr 3.89Cr 263.46Cr 3.95Cr 27Cr 11Cr 134.25Cr 10Cr 10Cr 432.35Cr EV / Sales 2026 *
-
EV / Sales 2027 * 5.86x
Free-Float
58.26%
Yield 2026 *
-
Yield 2027 * -
1 day-3.05%
1 week-3.05%
Current month-3.05%
1 month+6.00%
3 months+2.58%
6 months-14.52%
Current year-33.33%
1 week 3.13
Extreme 3.13
3.35
1 month 2.99
Extreme 2.99
3.35
Current year 2.77
Extreme 2.77
5.48
1 year 2.77
Extreme 2.77
12.15
3 years 1.2
Extreme 1.2
68.05
5 years 1.2
Extreme 1.2
1,252
10 years 1.2
Extreme 1.2
1,252
Manager TitleAgeSince
Chief Executive Officer 59 24/11/2025
Corporate Officer/Principal 49 11/08/2008
Director of Finance/CFO 53 01/11/2024
Director TitleAgeSince
Chairman 58 25/11/2020
Director/Board Member 56 01/01/2018
Director/Board Member 68 25/05/2021
Date Insider Type Main position Quantity % Market Cap. Importance
16/04/26 Other

Director

2,376 0.0006%
18/03/26 Other

Chief Financial Officer

6,45,750 0.1549%
18/03/26 OtherCompany 3,60,406 0.0864%
Change 5-day change 1-year change 3-year change Capi.($)
-3.05%-3.05%-15.43%-92.36% 2.74Cr
+4.16%-0.36%+49.37%+94.17% 7.45TCr
-0.61%+0.69%+36.36%+82.72% 6.01TCr
-2.54%-0.21%+6.34%+31.72% 4.82TCr
-3.02%-2.67%+37.26%+32.51% 4.43TCr
+0.31%+7.94%+340.88%+643.82% 4.4TCr
-1.96%-1.71%+5.30%+99.46% 4.16TCr
+3.32%+3.49%+11.18%+51.23% 3TCr
+4.77%+6.16%+36.77%+22.78% 2.93TCr
-4.86%-8.24%-24.60%+330.06% 2.49TCr
Average -0.35%+1.77%+48.34%+129.61% 3.97TCr
Weighted average by Cap. +0.17%+1.83%+60.06%+145.76%

Financials

2026 *2027 *
Net sales - 46.7L 41.54L 38.79L 35.39L 66.4L 45Cr 67.42L 4.68Cr 1.82Cr 23Cr 1.75Cr 1.72Cr 74Cr
Net income -1.56Cr -1.38Cr -1.29Cr -1.18Cr -2.21Cr -149.87Cr -2.25Cr -16Cr -6.05Cr -76Cr -5.84Cr -5.72Cr -245.94Cr -1.18Cr -1.05Cr -98.11L -89.52L -1.68Cr -113.77Cr -1.71Cr -12Cr -4.59Cr -58Cr -4.43Cr -4.34Cr -186.7Cr
Net Debt - -
Logo Evaxion A/S
Evaxion A/S, formerly known as Evaxion Biotech A/S, is a Denmark-based clinical-stage biotechnology company, which specializes in the development of AI-driven immunotherapies to improve the lives of patients with cancer and infectious diseases. The Company decodes the human immune system to discover and develop immunotherapies to treat cancer and infectious diseases. Based on AI-immunology core technology, Evaxion is developing a pipeline of product candidates. In addition, Evaxion develops portfolio of vaccines to prevent bacterial and viral infections.
Employees
46
Date Price Change Volume
01/26/01 $3.180 -3.05% 38,118
30/26/30 $3.280 +0.31% 18,053
29/26/29 $3.270 +0.93% 38,135
28/26/28 $3.240 -2.99% 55,694
25/26/25 $3.340 +2.45% 45,056
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.280USD
Average target price
11.25USD
Spread / Average Target
+242.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EVAX Stock